On Thursday, results from the World Health
Organization’s two-year trial studying the Ebola virus were published.
They indicate that the vaccine is effective — but it still needs to be
approved by regulatory agencies. Hari Sreenivasan speaks with Dr.
Anthony Fauci, director of the NIH’s National Institute of Allergy and
Infectious Diseases, about promising early results and remaining
challenges. Continue reading
No comments:
Post a Comment